US · Healthcare

Syndax Pharmaceuticals Inc (SNDX)

Biotechnology

Syndax Pharmaceuticals Inc (SNDX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SNDX

P/E ratio

25.00

Syndax Pharmaceuticals Inc (SNDX) — FAQ

What is SNDX's P/E ratio?

The price-to-earnings (P/E) ratio for Syndax Pharmaceuticals Inc (SNDX) is 25.00 (data as of 2026-05-24).

Does Syndax Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Syndax Pharmaceuticals Inc (SNDX). Check the MyAverix Finance app for the latest dividend data.

What sector is Syndax Pharmaceuticals Inc in?

Syndax Pharmaceuticals Inc (SNDX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SNDX listed on?

SNDX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)